Management of Junctional Rhythm with Bradycardia

Assessment and Treatment

• IV medications should be started for a patient with junctional rhythm and heart rate of 59 beats per minute only if the patient shows signs and symptoms of hemodynamic instability, such as acutely altered mental status, ischemic chest discomfort, acute heart failure, hypotension, or other signs of shock, as recommended by the American Heart Association 1, 2
• No immediate intervention is required for junctional rhythm with heart rate of 59 bpm if the patient is hemodynamically stable, but close monitoring is recommended to detect any deterioration, according to the American College of Cardiology 1, 2, 3
• The American Heart Association recommends atropine as the first-line treatment for symptomatic patients, with an initial dose of 0.5-1 mg IV, which may be repeated every 3-5 minutes as needed, with a maximum total dose of 3 mg, and a Class IIa recommendation, Level of Evidence B 1, 2, 4, 5
• For patients unresponsive to atropine, the American College of Cardiology suggests the use of β-adrenergic agonists with rate-accelerating effects, such as dopamine or epinephrine, with a Class IIa recommendation, Level of Evidence B 1, 2, 4
• Transcutaneous pacing is reasonable to initiate in unstable patients who do not respond to atropine, with a Class IIa recommendation, Level of Evidence B, as recommended by the American Heart Association 1, 2
• If no response to drugs or transcutaneous pacing, transvenous temporary pacing is probably indicated, with a Class IIa recommendation, Level of Evidence C, according to the American College of Cardiology 1, 2

Special Considerations

• Junctional rhythm specifics: Junctional rhythm is a narrow-complex tachycardia or bradycardia that arises from the AV junction, including the His bundle, as described by the American Heart Association 6, 7
• Medication cautions: Atropine may cause paradoxical high-degree AV block in patients after cardiac transplantation, and for patients with coronary artery disease, the American College of Cardiology recommends limiting the total atropine dose 1, 4, 5
• Overlooking underlying causes: Consider potential causes of junctional rhythm, such as medication effects, inferior myocardial infarction, or cardiac transplantation, as recommended by the American Heart Association 4, 5

Pitfalls to Avoid

• Delayed escalation: Don't delay transcutaneous pacing in unstable patients who fail to respond to atropine, as recommended by the American College of Cardiology 1, 2
• Overlooking underlying causes: Consider potential causes of junctional rhythm, such as medication effects, inferior myocardial infarction, or cardiac transplantation, as recommended by the American Heart Association 4, 5